Extended Data Fig. 10: Summary of findings of licogliflozin in NASH.

¹He, Y.L. et al. Diabetes Obes. Metab. 21, 1311–1321 (2019). ²Current study data. ALT, alanine aminotransferase; GLP-1, glucagon-like peptide 1; NASH, nonalcoholic steatohepatitis; SGLT, sodium–glucose cotransporters; wt, weight.